Who owns Scholar Rock Holding Corp (SRRK)? Elite investor 13F holders
4 tracked elite investors reported holding Scholar Rock Holding Corp as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Polen Capital Management, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | SCHOLAR ROCK HLDG CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 13476485.00 USD | 245027.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | SCHOLAR ROCK HLDG CORP | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 5032500.00 USD | 91500.000000 | Shares | buy | Original filing |
| Polen Capital Management | SCHOLAR ROCK HLDG CORP | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 2867260.00 USD | 52132.000000 | Shares | add | Original filing |
| Tudor Investment | SCHOLAR ROCK HLDG CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1442430.00 USD | 26226.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.